GEN Related Company Press Releases
-
GeneNews to Present at the Bloom Burton & Co. Healthcare Investor Conference
-
Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case
-
GeneNews Reports Q1 2013 Financial Results
-
Genmab Announces Financial Results for the First Quarter of 2013
-
Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocytic Leukemia
-
Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration
-
Arzerra First Quarter 2013 Net Sales Figures
-
Passing of Genmab A/S' Annual General Meeting
-
Genmab Announces Final US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit
-
GeneNews Announces Annual Shareholder Meeting
-
Daratumumab Granted Fast Track Designation From U.S. Food and Drug Administration
-
GeneNews Reports Q4 and Full Year 2012 Financial Results
-
Arzerra Receives Approval in Japan
Back to GEN Stock Lookup
